Legend Biotech (LEGN) Return on Capital Employed (2020 - 2025)
Legend Biotech (LEGN) posted Return on Capital Employed of 27.36% for Q4 2025, up 2.83% on a QoQ basis from 28.15% in Q3 2025, and down 1063.0% year-over-year from 2.84% in Q4 2024.
Legend Biotech (LEGN) Return on Capital Employed (2020 - 2025) Analysis & Trends
Legend Biotech's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 27.36% for Q4 2025.
- Quarterly Return on Capital Employed fell 1063.0% year-over-year to 27.36% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 27.36% (down 1063.0% YoY) and the FY2025 annual result came in at 12.81%, up 808.0% from the prior year.
- Return on Capital Employed was 27.36% for Q4 2025 at Legend Biotech, up from 28.15% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.04% in Q2 2021 and bottomed at 52.4% in Q4 2021.
- A 5-year average of 25.82% and a median of 27.67% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2021 — Return on Capital Employed slumped 5232 bps — and 2024, when it surged 2242 bps.
- Legend Biotech's Return on Capital Employed stood at 52.4% in 2021, then climbed by 7 bps to 49.0% in 2022, then soared by 38 bps to 30.35% in 2023, then soared by 45 bps to 16.72% in 2024, then slumped by 64 bps to 27.36% in 2025.
- Business Quant data shows LEGN's Return on Capital Employed at 27.36% in Q4 2025, 28.15% in Q3 2025, and 27.67% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -68.84% |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -27.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.36% |
| Sep 30, 2025 | -28.15% |
| Jun 30, 2025 | -27.67% |
| Mar 31, 2025 | -19.69% |
| Dec 31, 2024 | -16.72% |
| Sep 30, 2024 | -20.45% |
| Jun 30, 2024 | -18.21% |
| Mar 31, 2024 | -28.95% |
| Dec 31, 2023 | -30.35% |
| Sep 30, 2023 | -28.52% |
| Jun 30, 2023 | -39.81% |
| Mar 31, 2023 | -51.38% |
| Mar 31, 2022 | -49.00% |
| Dec 31, 2021 | -52.40% |
| Sep 30, 2021 | -0.08% |
| Jun 30, 2021 | -0.04% |
| Mar 31, 2021 | -0.08% |
| Dec 31, 2020 | -0.09% |
| Sep 30, 2020 | -0.04% |